394
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Comparison of Meibomian Gland Imaging Findings and Lipid Layer Thickness between Primary Sjögren Syndrome and Non-Sjögren Syndrome Dry Eyes

, &
Pages 182-187 | Received 04 Sep 2018, Accepted 19 Dec 2018, Published online: 22 Feb 2019
 

ABSTRACT

Purpose: To compare meibomian gland (MG) imaging findings and lipid layer thickness (LLT) between patients with primary Sjögren syndrome (SS) dry eyes (DE) and non-SS DE.

Methods: A total of 60 patients—30 with SS DE and 30 with non-SS DE were evaluated. Infrared image findings of MGs and LLT were assessed using the LipiView II interferometer.

Results: The maximum LLT was significantly lower in the SS DE group. SS DE exhibited significantly higher MG dropout compared to the non-SS DE. Average and maximal LLT showed significant negative correlations with MG dropout in both groups (p<0.05). Conjunctival staining scores showed significant correlations with average and maximum LLT and MG dropout values in the SS DE group (p<0.05).

Conclusion: These findings suggest that the new interferometer will be useful in understanding the pathophysiology of SS DE.

DECLARATION OF INTEREST

The authors report no conflict of interest.

Additional information

Funding

This work was supported by the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0016].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.